Detalhe da pesquisa
1.
Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 18(4): 435-445, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28284557
2.
Phase I Study of the Prolactin Receptor Antagonist LFA102 in Metastatic Breast and Castration-Resistant Prostate Cancer.
Oncologist
; 21(5): 535-6, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27091421
3.
Zenocutuzumab, a HER2xHER3 Bispecific Antibody, Is Effective Therapy for Tumors Driven by NRG1 Gene Rearrangements.
Cancer Discov
; 12(5): 1233-1247, 2022 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35135829
4.
Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma.
J Transl Med
; 8: 89, 2010 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-20875102
5.
Population Pharmacokinetics of MCLA-128, a HER2/HER3 Bispecific Monoclonal Antibody, in Patients with Solid Tumors.
Clin Pharmacokinet
; 59(7): 875-884, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32006223
6.
Sustained Tumor Regression With Zenocutuzumab, a Bispecific Antibody Targeting Human Epidermal Growth Factor Receptor 2/Human Epidermal Growth Factor Receptor 3 Signaling, in NRG1 Fusion-Positive, Estrogen Receptor-Positive Breast Cancer After Progression on a Cyclin-Dependent Kinase 4/6 Inhibitor.
JCO Precis Oncol
; 6: e2100446, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35977350
7.
Radiochemotherapy with short daily infusion of low-dose oxaliplatin, leucovorin, and 5-FU in T3-T4 unresectable rectal cancer: a phase II IATTGI study.
Int J Radiat Oncol Biol Phys
; 54(2): 397-402, 2002 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12243813
8.
Molecular pathways: blockade of the PRLR signaling pathway as a novel antihormonal approach for the treatment of breast and prostate cancer.
Clin Cancer Res
; 19(7): 1644-50, 2013 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23515410
9.
Phase I studies of CBP501, a G2 checkpoint abrogator, as monotherapy and in combination with cisplatin in patients with advanced solid tumors.
Clin Cancer Res
; 17(10): 3431-42, 2011 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21220472
10.
Pilot study using molecular profiling of patients' tumors to find potential targets and select treatments for their refractory cancers.
J Clin Oncol
; 28(33): 4877-83, 2010 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-20921468
11.
Irinotecan, oxaliplatin plus bolus 5-fluorouracil and low dose folinic acid every 2 weeks: a feasibility study in metastatic colorectal cancer patients.
Am J Clin Oncol
; 29(1): 45-51, 2006 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16462502
12.
Investigacion clinica en Oncologia / Clinical investigation in Oncology
Rev. argent. cancerol
; 29(2): 60-64, jul. 2001.
Artigo
em Espanhol
| LILACS | ID: lil-305506
13.
Investigacion clinica en Oncologia / Clinical investigation in Oncology
Rev. argent. cancerol
; 29(2): 60-64, jul. 2001.
Artigo
em Espanhol
| BINACIS | ID: bin-8903